Boston, MA -- (SBWIRE) -- 08/19/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (Dole Food Company, Inc.(NYSE:DOLE), Rentech, Inc.(NYSEAMEX:RTK), Keryx Biopharmaceuticals (NASDAQ:KERX), Integrated Products, Inc. (NASDAQ:MXIM)
Dole Food Company, Inc.(NYSE:DOLE) shares gained 0.07% to $13.46. DOLE and David H. Murdock, Dole's Chairman and Chief Executive Officer, on August 12 jointly announced that they have signed a definitive merger agreement pursuant to which Mr. Murdock, acting through his affiliates, will acquire for cash all of the outstanding shares of Dole common stock not currently beneficially held by him. Under the terms of the merger agreement, Dole stockholders will receive $13.50 in cash for each share of Dole common stock that they hold, in a transaction which (with the assumption of debt) places the total enterprise value of Dole at approximately $1.6 billion.
How Should Investors Trade DOLE After The Recent Volatility? Get Free Report Here
Rentech, Inc.(NYSEAMEX:RTK) shares closed at $1.98. The company on August 8 announced its results for the three and six months ended June 30, 2013, and updated its 2013 guidance. Revenues for the three months ended June 30, 2013 were $104.0 million, compared to $70.6 million for the comparable period in the prior year. Net income was $28.7 million or $0.74 per basic unit, for the current period.
How Should Investors Trade RTK After The Recent Volatility? Get Free Report Here
Keryx Biopharmaceuticals (NASDAQ:KERX) shares fell 2.33% to $8.38. The company on August 8 announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the marketing and sale of Zerenex™ (ferric citrate coordination complex), the Company's drug candidate for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with chronic kidney disease (CKD) on dialysis.
Is KERX A Good Buy After The Recent Price Movement? Find Out Here
Integrated Products, Inc. (NASDAQ:MXIM) on August 15 announced it has entered into a definitive agreement to acquire Volterra Semiconductor for $23 per share, which represents a 55% premium to Volterra Semiconductor's closing share price on August 14, 2013. The transaction value is approximately $605 million equity value or $450 million net of Volterra's cash position of approximately $155 million.
Additionally, Rigrodsky & Long, P.A. on August 15 announces that it is investigating potential legal claims against the board of directors of Volterra Semiconductor Corporation regarding possible breaches of fiduciary duties and other violations of law related to the Company's entry into an agreement to be acquired by Maxim Integrated Products, Inc. ("Maxim") (NASDAQ GS: MXIM) in a transaction valued at approximately $605 million.
Is MXIM A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)